How to investigate Adherence to Antiretroviral Treatment ... - INRUD

More documents

Recommendations

Info

How to Investigate Adherence to Antiretroviral Treatment in Health Facilities: Adherence Indicators o Example 3—If there are four doctors or clinical officers present for two days, and one for three days the number would be (4 + 4 + 1 + 1 + 1)/5=11/5 = 2.2 Q10, cont. Then the calculation for the number of patients per clinician per hour is (number of patients seen in a week) divided by (number of clinicians in an average clinic × the number of hours the clinic is open in a week). (This will be calculated automatically when the data is entered.) Q11. The purpose here is to find the number of non clinicians who work in an average clinic. If one person does more than one job, it is important to only count them once. So, if a nurse also does counselling, then she or he should only be counted once. If the person works in the community and not in the clinic, she or he should not be counted but should be mentioned below. Only paid professional staff based in the facility should be counted, so this does not include cleaners for example. How many of the following staff working directly with HIV/AIDS patients are present during a normal clinic? (Count each staff member only once while in the clinic.) Staff Nurses Social workers Nutritionist Counsellors Pharmacists No. Working Pharmaceutical technologist Other (specify) Q11, cont. Then the calculation for the number of HIV/AIDS patients per week per support staff is calculated by dividing the number of patients in a week by the number of support staff. (This will be calculated automatically when the data is entered.) Questionnaire Side Two Q12-14. For each question, enter Y/N—You must be able to see a copy of each guidelines asked for to mark a yes—t is not enough to be told there is one. Q15. If the manager says a guideline is followed to start a patient on ART, then write Y and name the guideline in the next square. Otherwise write N. Q16. Ask how many days supply of ARVs are usually given to patients during their first month of treatment. 48
Chapter 5. Data Collection Tools and How to Fill Them Q17. Ask how many days supply of ARVs are usually given to patients after their first month of treatment. Q18. Mark Y for all that apply Q19. Mark Y for all that apply Q20. Answer Y/N—The definition of a private space is where a conversation can be had without being overheard. Q21-22. Ask whether the programme provides child care, food for patients on ART, and have a formal system for linking patients with support of another person on ART. Answer each Y/N or S (sometimes).. Q 23. Ask whether the programme has formal links with the community such as churches or other organizations. Answer Y/N. Q24-25. Because there are so many different laboratory systems the two questions to ask are— • Do you have a functioning laboratory system for measuring CD4 counts, so that results can be ready for the patient's next routine visit? Answer Y/N. • Is both the test and transport for the test free for patients Answer Y/N.? The laboratory must be working and active that day. If it is not functioning then it does not count. If both Q24 and Q25 are Y, then the indicator of whether there is access to a laboratory for a CD4 count will also be Y. Otherwise the indicator will be N. Q26–28. Remember that the lists of medicines need preparing in advance. The ones given here are only suggestions. There are three columns for each of the three lists of drugs. The principles for filling in the three tables are the same. • The present Y/N column For the present column, the drugs must be available and in date. It does not matter how many of them there are. • For the number (#) of days in stock in last 90 days column For each formulation of each medicine mentioned it is necessary to look at the stock cards for the last 90 days and see how many of these days the drug has been in stock and mark that in the appropriate column. • Any stock in the last 90 days If the stock records are incomplete, it may be difficult or impossible to know the number of days each medicine has been in or out of stock in the 49
Page 1 and 2:
How to investigate Adherence to Ant
Page 3 and 4:
ACKNOWLEDGEMENTS This manual has be
Page 5 and 6: ACRONYMS AIDS ART ARV HIV IAA IHCAR
Page 7 and 8: CONTENTS Acknowledgements .........
Page 9 and 10: INTRODUCTION Collecting data on adh
Page 11 and 12: CHAPTER 1. OVERVIEW OF MANUAL The 2
Page 13 and 14: Chapter 1. Overview of Manual Table
Page 15 and 16: CHAPTER 2. CORE INDICATORS OF ADHER
Page 17 and 18: Chapter 2. Core Indicators of Adher
Page 19 and 20: Chapter 2. Core Indicators of Adher
Page 21 and 22: CHAPTER 3. INDICATORS FOR POSSIBLE
Page 23 and 24: Chapter 3. Indicators for possible
Page 31 and 32: CHAPTER 4. SURVEY DESIGN Sampling F
Page 33 and 34: Chapter 4. Survey Design Figure 1.
Page 35 and 36: CHAPTER 5. DATA COLLECTION TOOLS AN
Page 37 and 38: Chapter 5. Data Collection Tools an
Page 55: Chapter 5. Data Collection Tools an
Page 59 and 60: CHAPTER 6. PLANNING AND FIELD METHO
Page 61 and 62: Chapter 6. Planning and Field Metho
Page 67 and 68: CHAPTER 7. TRAINING OF DATA COLLECT
Page 69 and 70: Chapter 7. Training of Data Collect
Page 71 and 72: CHAPTER 8. DATA ENTRY AND DATA PROC
Page 73 and 74: Chapter 8. Data Entry and Data Proc
Page 75 and 76: Chapter 8. Data Entry and Data Proc
Page 78 and 79: How to Investigate Adherence to Ant
Page 82 and 83: CHAPTER 9. INTERPRETATION OF DATA A
Page 86 and 87: CHAPTER 10. REPORT OUTLINE When the
Page 100 and 101: How to investigate Adherence to Ant
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120:
show all

How to investigate Adherence to Antiretroviral Treatment ... - INRUD

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?